Slingshot members are tracking this event:
Vertex's Tezacaftor (VX-661) / ivacaftor in treating Cystic fibrosis - Two Copies of the F508del Mutation PDUFA date under priority review February 28, 2018
Slingshot Insights Explained
Feb 12, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Vx-661, Tezacaftor, Cystic Fibrosis, F508del Mutation